Medtronic PLC MDT
Stock research in plain language · As of Oct 04, 2026 · updated once a week, after the trading week closes
What the company does
Medtronic PLC is a large-cap company in the Healthcare sector (Medical Devices), with a market value of $110.5B, based in the USA.
It employs about 95,000 people and has been listed since Jan 13, 1978.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Cheap or expensive? relatively cheap
Its price-to-earnings (P/E) is 21.3 versus 31.6 for the median of the Healthcare sector in our universe (22 companies) — relatively cheap.
Revenue is growing 14% versus the same quarter last year.
On analysts' next-year forecasts the multiple drops to 14.9 — they expect higher earnings.
The average analyst price target is 104.83, 21% above the current price (their view, not ours).
The stock sits at 46% of its one-year range (0% = the low, 100% = the high).
The risks
- No risk flags were detected from the data we have.
Strengths
- ✅ Profitable — 15 of every 100 dollars of revenue stays as profit.
- ✅ Generates free cash flow — profit becomes cash in the bank.
- ✅ Most analysts rate it buy (19 vs 0).
- ✅ Pays a dividend (3.3% a year).
What changed this week
Over the past week the stock fell 2.5% (for comparison: S&P 500 -0.2%, sector ETF XLV -2.6%).
This week's news
- Medtronic Has Been Boring Investors for Years. That Could Be Changing finance.yahoo.com · 2026-10-03
- 3 AI Healthcare Stocks With Earnings Growth Up To 15% finance.yahoo.com · 2026-10-02
- Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its Allure finance.yahoo.com · 2026-10-02
- Can ISRG Offset China Weakness With Expansion in India and Japan? finance.yahoo.com · 2026-10-02
- Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems finance.yahoo.com · 2026-10-01
- Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report? finance.yahoo.com · 2026-10-01
A description of facts from the filings and the market — not investment advice or a recommendation. "Cheap" and "expensive" are always relative to the comparison group.